TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 NOK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
14,877
|
13,143
|
11,284 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
682
|
345
|
302 |
EBITDA |
901
|
558
|
310 |
Total assets |
6,220
|
5,317
|
4,477 |
Current assets |
5,525
|
4,473
|
4,450 |
Current liabilities |
2,009
|
1,520
|
1,249 |
Equity capital |
3,963
|
3,537
|
3,007 |
- share capital |
50
|
52
|
48 |
Employees (average) |
4
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
63.7%
|
66.5%
|
67.2% |
Turnover per employee |
3,719
|
4,381
|
3,761 |
Profit as a percentage of turnover |
4.6%
|
2.6%
|
2.7% |
Return on assets (ROA) |
11.0%
|
6.5%
|
6.7% |
Current ratio |
275.0%
|
294.3%
|
356.3% |
Return on equity (ROE) |
17.2%
|
9.8%
|
10.0% |
Change turnover |
2,132
|
875
|
98 |
Change turnover % |
17%
|
7%
|
1% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
33%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.